Loading
AP
Anthera Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by THOMPSON JOHN CRAIG, was filed 20 Sept 2017.
Anthera Pharmaceuticals Inc: what insiders have been doing
Anthera Pharmaceuticals Inc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Anthera Pharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 20 September 2017.
The full history, which starts in 2010, counts 18 purchases against 103 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
300
Thresholds
n/a
Buy Volume
€4M
18 ops. · all time
Sell Volume
€14M
103 ops. · all time
Since the insiders bought
- -8.5%Entry 29.64 · Close at T+365 27.12
- -26.1%Entry 35.19 · Close at T+365 26.00
- -48.1%Entry 44.16 · Close at T+365 22.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Revenue129.3k
Net income-24M-18533.8% margin
Last declaration on 20 September 2017
Declarations300 total
8,550 shares@ US$1.3243.5% of flowCommon stockSEC:0001214659-17-005694:0
Canonical exit: 19 Dec 2017 (T+90)
10,400 shares@ US$1.4356.5% of flowCommon stockSEC:0001214659-17-005528:0
5,000 shares@ US$1.3437.4% of flowCommon StockSEC:0001214659-17-005551:0
Canonical exit: 6 Dec 2017 (T+90)
5,008 shares0Common stockSEC:0001214659-16-013774:1
5,008 shares0Common stockSEC:0001214659-16-013774:2
5,008 shares@ US$2.0862.6% of flowCommon stockSEC:0001214659-16-013774:0
10,000 shares@ US$2.89Common stockSEC:0001214659-15-008517:0
12,500 shares@ US$1.61Common StockSEC:0001214659-15-007879:0
12,500 shares@ US$5.31Common StockSEC:0001214659-15-007879:1
5,000 shares@ US$5.38Common StockSEC:0001214659-15-007703:0
1,205 shares@ US$6.15Common StockSEC:0001214659-15-007104:0
12,500 shares0Common StockSEC:0001214659-15-000043:0
12,500 shares0Common StockSEC:0001214659-15-000043:1
1,364 shares0Common StockSEC:0001214659-15-000048:0
1,364 shares0Common StockSEC:0001214659-15-000048:1
2,000 shares@ US$2.08Common StockSEC:0001214659-14-004814:0
699 shares@ US$3.39Common StockSEC:0001214659-14-004814:1
16,500 shares0Common StockSEC:0001214659-14-004814:2
14,709 shares0Common StockSEC:0001214659-14-004814:3
3,864 sharesCommon StockSEC:0001214659-14-002330:1
1,352 shares@ US$3.30Common StockSEC:0001214659-14-002330:2
6,250 shares@ US$3.30Common StockSEC:0001214659-14-002330:3
529 shares@ US$3.30Common StockSEC:0001214659-14-002288:0
3,625 sharesCommon StockSEC:0001214659-14-002288:1
7,622 shares@ US$3.30Common StockSEC:0001214659-14-002286:0
25 of 300 declarations
About Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for autoimmune diseases and cardiovascular conditions. It is listed on NASDAQ under the ticker ANTH.
